BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18203329)

  • 1. Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.
    Lisbona MP; Maymo J; Perich J; Almirall M; Pérez-García C; Carbonell J
    J Rheumatol; 2008 Mar; 35(3):394-7. PubMed ID: 18203329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept.
    Lisbona MP; Maymó J; Perich J; Almirall M; Carbonell J
    Ann Rheum Dis; 2010 Jun; 69(6):1117-22. PubMed ID: 20448287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
    Quinn M
    J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks.
    Boesen M; Boesen L; Jensen KE; Cimmino MA; Torp-Pedersen S; Terslev L; Koenig M; Danneskiold-Samsøe B; Røgind H; Bliddal H
    J Rheumatol; 2008 Apr; 35(4):584-91. PubMed ID: 18322991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.
    Migliore A; Massafra U; Bizzi E; Argento G; Diamanti AP; Germano V; Tormenta S; Arduini F; Iannessi F; Granatas M; Laganà B
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):363-9. PubMed ID: 22530354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
    Gerlag DM; Haringman JJ; Smeets TJ; Zwinderman AH; Kraan MC; Laud PJ; Morgan S; Nash AF; Tak PP
    Arthritis Rheum; 2004 Dec; 50(12):3783-91. PubMed ID: 15593225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of very early treatment in rheumatoid arthritis on bone oedema and synovitis, using magnetic resonance imaging.
    Kosta PE; Voulgari PV; Zikou AK; Tsampoulas K; Drosos AA; Argyropoulou MI
    Scand J Rheumatol; 2012 Oct; 41(5):339-44. PubMed ID: 22646866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
    Kruithof E; De Rycke L; Roth J; Mielants H; Van den Bosch F; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
    Suzuki Y; Inoue K; Chiba J; Inoue Y; Kanbe K
    Int J Rheum Dis; 2009 Apr; 12(1):7-13. PubMed ID: 20374310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.
    Zikou AK; Argyropoulou MI; Voulgari PV; Xydis VG; Nikas SN; Efremidis SC; Drosos AA
    J Rheumatol; 2006 Feb; 33(2):219-23. PubMed ID: 16465650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
    Baraliakos X; Davis J; Tsuji W; Braun J
    Arthritis Rheum; 2005 Apr; 52(4):1216-23. PubMed ID: 15818694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation and differential response to therapy for knee synovitis adjacent to the cartilage-pannus junction and suprapatellar pouch in inflammatory arthritis: implications for pathogenesis and treatment.
    Rhodes LA; Tan AL; Tanner SF; Radjenovic A; Hensor EM; Reece R; O'Connor P; Emery P; McGonagle D
    Arthritis Rheum; 2004 Aug; 50(8):2428-32. PubMed ID: 15334454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
    Guis S; Balandraud N; Bouvenot J; Auger I; Toussirot E; Wendling D; Mattei JP; Nogueira L; Mugnier B; Legeron P; Landt O; Serre G; Roudier J; Roudier C
    Arthritis Rheum; 2007 Dec; 57(8):1426-30. PubMed ID: 18050183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis.
    Graham TB; Laor T; Dardzinski BJ
    J Rheumatol; 2005 Sep; 32(9):1811-20. PubMed ID: 16142882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept in severe active rheumatoid arthritis: first Australian experience.
    Perera LC; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
    Intern Med J; 2006 Oct; 36(10):625-31. PubMed ID: 16958637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.